Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer;Etude cas-témoins des gènes des récepteurs des androgènes, de la vitamine-D et de la 5-alpharéductase dans une population Afro-Antillaise de cancer de prostate

Progres en Urologie

Volumn 16, Issue 3, 2006, Pages 303-310

  Veronique Baudin, Jacqueline ^a,b,c   Dieye, Moustapha ^a,b,c   Kouyoumdjian, Jean Claude ^d   Vacheron, Francis ^d   Draganescu, Cyprian ^b   Azaloux, Hervé ^a,b,c  

^a AMREC ^*  (Martinique)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

5 alphareductase D vitamin receptors; Afro Caribbean population; Androgen receptors; Cancer

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL RECEPTOR; CELL RECEPTOR; CHOLESTENONE 5ALPHA REDUCTASE;

AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; HUMAN; MALE; MARTINIQUE; PROSTATE TUMOR;

AGED; CASE-CONTROL STUDIES; CHOLESTENONE 5 ALPHA-REDUCTASE; HUMANS; MALE; MARTINIQUE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 33748039108     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. (http:::www.dep.iarc.fr:2001).
2. 23-INVS.: "Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000". Edition 2003.
3. BRIOLLAIS L., AZALOUX H., ESCARMANT P., DORIVAL M.J., MICOULLOUD A.: Martinique Cancer Registry. In: Cancer Incidence in Five Continents. Vol. VIII. Edited by Parkin D.M., Whelan S.L., Ferlay J., Thomas D.B., IARC Scientific, 2002; 155.
4. DIEYE M., AZALOUX H., ESCARMANT P., DORIVAL M.J., VÉRONIQUE-BAUDIN J.: L'incidence et la mortalité du cancer en Martinique de 1996 à 2000. Monographie du Registre des Cancers de la Martinique. France - 2004.
5. CORREA-CERRO L., WOHR G., HAUSSLER J., BERTHON P., DRELON E., MANGIN P., FOURNIER G., CUSSENOT O., KRAUSS P., JUST W., PAISS T., CANTU J.M., VOGEL W.: (CAG)n CAA and CGN repeats in the human receptor gene are not associated with prostate cancer in a French-German population. Eur. J. Hum. Genet., 1999; 7: 357-362.
6. DAVIS D.L., RUSSELL D.W.: Unsual length polymorphism in human steroid 5-alpha-reductase type 2 gene (SRD5A2). Hum. Molec. Genet., 1993; 2: 820.
7. EDWARDS A., HAMMOND H.A., JIN L. ET AL.: Genetic variation at five trimeric and tretrameric tamden repeat loci in four human populations. Genomic, 1992; 12: 241-252.
8. HAKIMI J.M., SCHOENBERG M.P., RONDENELLI R.H., PIANTADOSI S., BARRACK E.R.: Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin. Cancer Res., 1997; 3: 1599-1608.
9. IRVINE R.A., YU M.C., ROSS R.K., ET AL.: The CAG and GGC microsatellites of the androgen receptor are in linkage disequilibrium in men with prostate cancer. Cancer Res., 1995; 55: 1937-1940.
10. INGLES S.A., ROSS R.K., YU M.C. ET AL.: Association of prostate cancer risk with genetic polymorphisms in vitamin-D receptor and androgen receptor. J. Natl Cancer Inst, 1987; 89: 166-170.
11. GIOVANNUCI E., DTANFER M.J., KRITHIVAS K.: The CAG repeat within the androgen-receptor gene and its relationship to prostate cancer. Proc. Natl Acad. Sci., 1997; 94: 3320-3323.
12. BRATT O., BORG A., KRISTOFFERSSON U., LUNDGREN R., ZHANG Q.X., OLSSON H.: CAG repeat length in the androgen receptor gene is related to ageat diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br. J. Cancer, 1999; 81: 672-676.
13. EDWARDS S.M., BADZIOCH M.D., MINTER R., HAMOUDI R., COLLINS N., ARDERN-JONES A., DOWE A., OSBORNE S., KELLY J., SHEARER R., EASTON D.F., SAUNDERS G.F., DEARNALEY D.P., EELES R.A.: Androgen receptors polymorphisms: association with prostate cancer risk, relapse and overall survival. Int. J. Cancer, 1999; 84: 458-465.
14. MENEGOZ F., CHERIE-CHALLINE L.: Le cancer en France. 1998, Edited by Réseau Francim.
15. GAO X., ZACHAREK A., SALKOWSKI A., GRIGNON D.J., SAKR W., PORTER A.T., HONN K.V.: Loss of heterozygotiy of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res., 1995; 55: 1002-1005.
16. HANCHETTE C.L., SCHWARTZ G.G.: Geographic patterns of prostate cancer mortality. Cancer (Phila), 1992; 70: 2861-2869.
17. HANNAH S.S., NORMAN A.W.: 1-a,25(OH)2vitamin-D3 regulated expression of the eukaryotic genome. Nutr. Rev., 1994; 52: 376-382.
18. SKOWRONSKI R.J., PEEHL D.M., FELDMAN D.: Vitamin D and prostate cancer: 1,25-dihydroxyvitamin-D3 receptors and actions in human prostate cancer cell lines. Endocrinology, 1993; 132: 1952-1960.
19. MORRISON N.A., QI J.C., TOKITA A., KELLY P.J., CROFTS L., NGUYEN T.V. ET AL.: Prediction of bone density from Vitamin D receptors alleles. Nature, 1994; 367: 284-287.
20. BLAZER D.G., 3RD, UMBACH D.M., BOSTICK R.M., TAYLOR J.A.: Vitamin D receptor polymorphism and prostate cancer. Mol. Carcinog., 2000; 27: 18-23.
21. CORREA-CERRO L., BERTON P., HAUSSLER J., BOCHUM S., DRELON E., MANGIN P., FOURNIER G., PAISS T., CUSSENOT O., VOGEL W.: Vitamin D receptor polymorphism as markers in prostate cancer. Hum Genet, 1999; 105: 281-287.
22. WATANABE M., FUKUTOMEK K., MURATA M., UEMURA H., KUBOTA Y., KAWAMARA J., YATANI R.: Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese. Anticancer Res., 1999; 5: 4511-4514.
23. STUDZINSKI G.P., MAC LANE J.A., USKOKOVIC M.R. Signaling pathway for vitamin-D induced differenciation: implications for therapy of proliferative and neoplastic disease. Crit. Rev. Eukaryot Gene Expr., 1993; 3: 279-312.
24. BINDERUP L., BRAMM E.: Effects of a novel vitamin D analogue MC903 on cell proliferation and differenciation in vitro and a calcium metabolism in vivo. Biochem. Pharmacol., 1988; 37: 889-895.
25. COLSTON K. W., BERGER U., COOMBES R.C.: Possible role of vitamin D in controlling breast cancer cell proliferation. Lancet, 1989; 8631: 188-191.
26. REICHARDT J.K.V., MAKRIDAKIS N., HENDERSON B.E., YU M.C., PIKE M.C., ROSS R.K.: Genetic variability of the human SRD5A2 gene implication for prostate, cancer risk. Cancer Res., 1995; 55: 3973-3975.
27. THIGPEN A.E., DAVIS D.L., MILATOVICH A., MENDONCA B.B., IMPERATO-MCGINLEY J., GRIFFIN J.E., FRANCKE U., WILSON J.D., RUSSELL D.W.: Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J. Clin. Invest., 1992; 90: 799-809.
28. KANTOFF P.W., FEBBO P.G., GIOVANNUCCI E., KRITHIVAS K., M.DAHL D., CHANG G., HENNEKENS C.H., BROWN M., STAMPFER M.J.: A pymorphsm of the 5a-reductase gene and its association with prostate cancer: a case-control analysis. Cancer Epidemiology, 6: 189-192.
29. KANTOFF P.W., FEBBO P.G., GIOVANNUCCI E., KRITHIVAS K., M.DAHL D., CHANG G., HENNEKENS C.H., BROWN M., STAMPFER M.J. A pymorphsm of the 5a-reductase gene and its association with prostate cancer: a case-control analysis. Cancer Epidemiology, 6: 189-192.
30. STANFORD J.L., JUST J.J., GIBBS M. ET AL.: Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk. Cancer Res., 1997; 57: 1194-1198.
31. INGLES S.A., GERHARD COETZEE A., ROSS R. K., HENDERSON B. E., KOLONEL L.N., CROCITTO L., WANG W. R., HAILE W.: Association of prostate cancer with vitamin D haplotypes in African-Americans. Cancer Research, 1998; 58: 1620-1623.
32. INGLES S.A., ROSS R.K., YU M.C., IRVINE R.A., LA PERA G., HAILE R.W., COETZEE G.A.: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer Inst., 1997; 89: 166-170.
33. CORDER E.H., GUESS H.A., HULKA B.S. ET AL.: Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev., 1993; 2: 467-472.
34. MAKRIDADIS N.M., ROSS R.K., PIKE M.C., CROCITTO L.E., KOLONEL L.N., PEARCE C.L., HENDERSON B.E., REICHARDT J.K.: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet, 1999; 354: 975-978.
35. ROSS R.K., PIKE M.C., COETZEE G.A., REICHARDT J.K., YU M.C., FEIGELSON H., STANCZYK F.Z., KOLONEL L.N., HENDERSON B.E.: Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res., 1998; 58: 4497-4504.